Product Information
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.0728 per ML under NDC 69238145802. Its NADAC has been published 424 times since Aug 22, 2018.
FDA first approved this application on Jul 19, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
3 g/15mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238145802
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210041FDA Approved
7/19/2018
TE Code
AA
On Market Since
7/24/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 424 times since Aug 22, 2018, and over the history we have for it it has declined 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0728 per ML |
|---|---|
| All-time high | $0.9084 (Dec 12, 2018) |
| All-time low | $0.0440 (Dec 17, 2025) |
| 52-week high | $0.0778 |
| 52-week low | $0.0440 |
| Median price | $0.2192 |
| Average price | $0.3556 |
| Largest weekly change | +163.0% (Jan 18, 2023) |
| Weeks tracked | 424 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Potassium Chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Amneal Pharmaceuticals NY LLC, is $0.0728 per ML (NDC 69238145802), effective Sep 30, 2026.
How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 91.8%. It has been tracked across 424 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Since Aug 22, 2018, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.9084 (Dec 12, 2018), with a median of $0.2192 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 69238145802) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.